FIA
ITOS

FNY Investment Advisers’s iTeos Therapeutics ITOS Stock Holding History

FNY Investment Advisers’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-65,000
Closed -$648K – 1369
2025
Q2 		$648K Buy
+65,000
New +$524K 0.27% 104

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FNY Investment Advisers's ITOS Position: Q3 2025 in Review

FNY Investment Advisers sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 65,000 shares — an estimated $648K sold.

FNY Investment Advisers first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $648K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • FNY Investment Advisers reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 65,000 iTeos Therapeutics shares in Q3 2025, an estimated $648K.
  • FNY Investment Advisers first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
  • FNY Investment Advisers's iTeos Therapeutics position peaked at $648K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.